Comments
Drug firm AstraZeneca Pharma India on Monday reported a 13.38 per cent decline in its net profit to ₹18.63 crore for the quarter ended June.
The company had posted a net profit of ₹21.51 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.
Revenue from operations stood at ₹193.57 crore for the quarter under consideration. It was ₹204.56 crore for the same period year ago, it added.
The board of directors has declared an interim dividend of ₹2 per equity share for the financial year 2020-21, the filing said.
Shares of AstraZeneca Pharma India were trading at ₹3,381.65 per scrip on BSE, up 1.50 per cent over previous close.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.